BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Ampion inflammation data

Ampio reported data from a double-blind, U.S. trial in 20 patients showing that twice-daily intranasal Ampion for 10 days led to a trend toward improvement in reflective TNSS compared to patients who received saline. Details were not disclosed. In...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >